Pamela Maffioli Selected Research

Acarbose

1/2017	Retraction notice to "Acarbose on insulin resistance after an oral fat load: a double-blind, placebo controlled study".
11/2015	Effect of Acarbose on Glycemic Variability in Patients with Poorly Controlled Type 2 Diabetes Mellitus Receiving Stable Background Therapy: A Placebo-Controlled Trial.
11/2012	α-Glucosidase inhibitors and their use in clinical practice.
6/2012	Efficacy and safety profile evaluation of acarbose alone and in association with other antidiabetic drugs: a systematic review.
7/2011	RETRACTED: Acarbose on insulin resistance after an oral fat load: a double-blind, placebo controlled study.
1/2011	Acarbose actions on insulin resistance and inflammatory parameters during an oral fat load.
12/2009	Modulation of adipokines and vascular remodelling markers during OGTT with acarbose or pioglitazone treatment.
3/2009	Metabolic effect of repaglinide or acarbose when added to a double oral antidiabetic treatment with sulphonylureas and metformin: a double-blind, cross-over, clinical trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pamela Maffioli Research Topics

Disease

52	Insulin Resistance 01/2022 - 05/2008
40	Type 2 Diabetes Mellitus (MODY) 01/2022 - 11/2008
35	Body Weight (Weight, Body) 01/2021 - 01/2009
18	Inflammation (Inflammations) 01/2021 - 03/2010
12	Hypertension (High Blood Pressure) 11/2020 - 03/2010
6	Dyslipidemias (Dyslipidemia) 11/2020 - 04/2009
6	Hypoglycemia (Reactive Hypoglycemia) 01/2020 - 06/2010
6	Atherosclerosis 01/2018 - 06/2010
5	COVID-19 03/2021 - 01/2021
5	Hypercholesterolemia 11/2020 - 01/2012
5	Glucose Intolerance 09/2020 - 06/2012
5	Obesity 01/2018 - 05/2012
5	Overweight 05/2016 - 05/2008
4	Cardiovascular Diseases (Cardiovascular Disease) 12/2019 - 04/2013
4	Neoplasms (Cancer) 01/2018 - 01/2016
4	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 08/2015 - 06/2010
3	Hyperlipidemias (Hyperlipidemia) 01/2022 - 07/2014
3	Essential Hypertension 02/2017 - 01/2013
3	Weight Loss (Weight Reduction) 01/2017 - 09/2011
3	Chronic Disease (Chronic Diseases) 01/2016 - 01/2016
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2015 - 12/2011
2	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2018
2	Nausea 01/2020 - 03/2009
2	Heart Failure 01/2019 - 01/2018
2	Metabolic Diseases (Metabolic Disease) 12/2017 - 06/2012

Drug/Important Bio-Agent (IBA)

36	Insulin (Novolin)FDA Link 03/2022 - 01/2010
36	LipidsIBA 01/2021 - 04/2009
33	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 12/2009
24	C-Reactive ProteinIBA 09/2020 - 01/2010
21	Metformin (Glucophage)FDA LinkGeneric 01/2017 - 05/2008
20	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021 - 01/2010
16	ResistinIBA 01/2021 - 05/2008
15	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 05/2008
14	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2010
13	AdiponectinIBA 01/2020 - 05/2008
12	Amlodipine (Norvasc)FDA LinkGeneric 07/2015 - 06/2010
11	Hypoglycemic Agents (Hypoglycemics)IBA 03/2022 - 08/2009
10	oxidized low density lipoproteinIBA 01/2022 - 01/2010
10	Nicotinamide PhosphoribosyltransferaseIBA 01/2021 - 01/2010
9	Vitamin A (Retinol)FDA LinkGeneric 05/2015 - 01/2010
8	HDL CholesterolIBA 11/2020 - 01/2010
8	Sitagliptin Phosphate (Januvia)FDA Link 10/2019 - 06/2010
8	Pioglitazone (Actos)FDA Link 01/2018 - 11/2008
8	Acarbose FDA LinkGeneric 01/2017 - 03/2009
7	Triglycerides (Triacylglycerol)IBA 01/2021 - 01/2010
7	LDL CholesterolIBA 11/2020 - 01/2010
7	CholesterolIBA 11/2020 - 01/2010
7	Glucagon (Glukagon)FDA Link 07/2014 - 06/2012
6	VildagliptinIBA 01/2017 - 06/2012
6	sibutramine (Meridia)FDA Link 01/2017 - 11/2008
6	ProinsulinIBA 07/2014 - 06/2010
6	olmesartanIBA 01/2014 - 08/2010
5	AdipokinesIBA 01/2021 - 12/2012
5	Interleukin-6 (Interleukin 6)IBA 01/2020 - 03/2010
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 02/2015
5	CanrenoneIBA 01/2019 - 11/2013
5	Pharmaceutical PreparationsIBA 05/2015 - 05/2008
5	Carnitine (L-Carnitine)FDA LinkGeneric 05/2015 - 01/2010
4	QuercetinIBA 03/2021 - 01/2021
4	CurcuminIBA 03/2018 - 01/2016
4	Rosiglitazone (Avandia)FDA Link 01/2018 - 05/2008
4	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2018 - 01/2012
4	BerberineIBA 01/2017 - 01/2012
4	Arginine (L-Arginine)FDA Link 08/2013 - 06/2012
4	C-PeptideIBA 08/2013 - 06/2012
4	Orlistat (Xenical)FDA Link 05/2012 - 01/2010
4	LeptinIBA 10/2011 - 05/2008
3	Biological ProductsIBA 01/2022 - 01/2011
3	Antiviral Agents (Antivirals)IBA 03/2021 - 01/2021
3	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 11/2012
3	PolyphenolsIBA 03/2018 - 12/2017
3	AldosteroneIBA 01/2018 - 11/2013
3	red yeast riceIBA 01/2017 - 08/2013
3	Losartan (Cozaar)FDA LinkGeneric 04/2016 - 01/2011
3	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2016 - 01/2011
3	Metalloproteases (Metalloproteinases)IBA 02/2015 - 04/2009
3	Exenatide (Byetta)FDA Link 08/2013 - 09/2011
3	Ramipril (Altace)FDA LinkGeneric 01/2013 - 01/2011
3	Telmisartan (Micardis)FDA Link 06/2012 - 11/2011
3	ThiazolidinedionesIBA 06/2012 - 11/2008
3	candesartanIBA 12/2011 - 03/2010
2	Thrombin FDA Link 03/2021 - 01/2021
2	Viral ProteinsIBA 03/2021 - 01/2021
2	AntioxidantsIBA 01/2021 - 01/2011
2	Plasminogen Activator Inhibitor 1IBA 01/2021 - 12/2011
2	Plasminogen Activators (Plasminogen Activator)IBA 01/2021 - 12/2011
2	Therapeutic UsesIBA 01/2021 - 01/2016
2	Receptor for Advanced Glycation End ProductsIBA 01/2020 - 01/2017
2	CytokinesIBA 01/2020 - 01/2016
2	coenzyme Q10 (CoQ10)IBA 01/2019 - 01/2017
2	PhytochemicalsIBA 01/2018 - 01/2016
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2018 - 06/2012
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 06/2012
2	Histones (Histone)IBA 01/2018 - 01/2017
2	Angiotensin Receptor AntagonistsIBA 01/2018 - 02/2014
2	CarbohydratesIBA 01/2018 - 06/2012
2	PotassiumIBA 01/2018 - 02/2015

Therapy/Procedure

37	Therapeutics 01/2022 - 05/2008
30	Glycemic Control 01/2018 - 05/2008
2	Drug Therapy (Chemotherapy) 11/2020 - 05/2012